Claims
- 1. A pharmaceutical composition in the form for oral administration in the prevention of inflammation in mammals comprising an effective inflammation-alleviating amount of at least one phospholipid and a non-steroidal inflammation-preventing compound selected from the group consisting of salicylic acid and derivatives thereof, said phospholipid and said compound being present in a molar ratio ranging from about 0.1:1 to about 20:1, respectively.
- 2. The composition of claim 1 wherein the inflammation-preventing compound and the at least one phospholipid are present in molar ratios ranging from about 1:0.5 to about 1:2.
- 3. The composition of claims 1 or 2 wherein the at least one phhospholipid is phosphatidylcholine.
- 4. The composition of claims 1 or 2 wherein the at least one phospholipid comprises phosphatidylcholine and phosphatidylinositol.
- 5. The composition of claims 1 or 2 wherein the inflammation-preventing compound is salicylic acid.
- 6. The composition of claim 5 wherein the inflammation-preventing compound is acetyl-salicylic acid.
- 7. The composition of claims 1 or 2 wherein the inflammation-preventing compound is salicylic acid amide.
- 8. The composition of claims 1 or 2 wherein the inflammation-preventing compound is benorilate.
- 9. The composition of claims 1 or 2 wherein the inflammation-preventing compound is difunisal.
- 10. The composition of claim 7 comprising acetyl salicylic acid and phosphatidylcholine which are present in a molar ratio ranging from about 1:0.2 to about 1:2.
- 11. A method of alleviating inflammation in a mammal comprising orally administering to said mammal an effective inflammation-alleviating amount of a pharmaceutical composition comprising at least one phospholipid and a non-steroidal inflammation-preventing compound selected from the group consisting of salicylic acid and derivatives thereof, said phospholipid and said compound being present in a molar ratio ranging from about 0.1:1 to about 20:1, respectively.
- 12. The method of claim 11 wherein said compound is salicylic acid.
- 13. The method of claim 11 wherein said compound is acetyl-salicylic acid.
- 14. The method of claim 11 wherein the at least one phospholipid is selected from the group consisting of phosphatidylcholine, phosphatidylinositol and mixtures thereof.
- 15. The method of claim 11 wherein said compound is salicylic acid amide.
- 16. The method of claim 11 wherein said compound is benorilate.
- 17. The method of claim 11 wherein said compound is difunisal.
Parent Case Info
This is a division of application Ser. No. 104,449 filed Dec. 17, 1979 now U.S. Pat. No. 4,332,795.
Divisions (1)
|
Number |
Date |
Country |
Parent |
104449 |
Dec 1979 |
|